secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2025-01-08T23:59:59+00:00
Accession:  0000950170-25-003280
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint appoints Dr. Reginald Sanders, retina specialist and former ASRS president, to board
--------------------------------------------------------------------------------

- Board expanded to nine members; Dr. Sanders appointed effective Jan 8, 2025.
- Receives $45,000 annual cash retainer and option for 80,000 shares vesting over 3 years.
- Sanders brings expertise as ex-president of American Society of Retina Specialists and PI for Lucentis.
- He served as president and managing partner of Retina Group of Washington, largest U.S. retina practice.
- Appointment coincides with Phase 3 trials for wet AMD and positive interim Phase 2 DME data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000095017025003280/0000950170-25-003280-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000095017025003280/eypt-20250108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-003280

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer